BIOTIPRA: BIOmarker-guided Treatment Decisions in Psoriatic and Rheumatoid Arthritis

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2027

Conditions
Arthritis, Rheumatoid
Interventions
DIAGNOSTIC_TEST

Tests for drug levels and anti-drug antibodies

Measurement of drug levels and anti-drug antibodies will be undertaken using commercially available enzyme-linked immunosorbent assays (ELISAs) and/or radioimmunoassays

Trial Locations (9)

M13 9PT

Centre for Musculoskeletal Research, Manchester

RG24 9NA

Hampshire Hospitals NHS Foundation Trust, Basingstoke

ST16 3AG

Midlands Partnership NHS Foundation Trust, Stafford

LE1 5WW

Leicester Royal Infirmary, Leicester

E9 6SR

Homerton University Hospital NHS Foundation Trust, London

M13 9WL

Manchester University Hospitals NHS Foundation Trust, Manchester

M5 5AP

Northern Care Alliance NHS Group, Manchester

TQ2 7AA

Torbay and South Devon NHS Foundation Trust, Torquay

WV10 0QP

Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors
lead

University of Manchester

OTHER